Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

被引：0
|
作者：
Edoardo Caronna
Victor José Gallardo
Alicia Alpuente
Marta Torres-Ferrus
Patricia Pozo-Rosich
机构：
[1] Universitat Autònoma de Barcelona,Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine
[2] Universitat Autònoma de Barcelona,Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Medicine
来源：
The Journal of Headache and Pain | 2021年 / 22卷
关键词：
Migraine; Medication overuse; CGRP; Monoclonal antibodies; Erenumab; Galcanezumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10) : 927 - 937
  • [32] Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies
    Nociti, Viviana
    Romozzi, Marina
    Annovazzi, Pietro
    Fantozzi, Roberta
    Tortorella, Carla
    Vercellino, Marco
    Iannone, Luigi Francesco
    De Luca, Giovanna
    Tomassini, Valentina
    Di Filippo, Massimiliano
    Lorefice, Lorena
    Maniscalco, Giorgia Teresa
    Paolicelli, Damiano
    Pinardi, Federica
    Ronzoni, Marco
    Solaro, Claudio Marcello
    Gasperini, Claudio
    Calabresi, Paolo
    Vollono, Catello
    Cocco, Eleonora
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2025, 469
  • [33] It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
    Kubota, Gabriel Taricani
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (05) : 218 - 226
  • [34] Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
    Krymchantowski, Abouch V. V.
    Jevoux, Carla
    Krymchantowski, Ana Gabriela
    Silva-Neto, Raimundo Pereira
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [35] Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine
    Van der Arend, Britt W. H.
    Van Veelen, Nancy
    De Ruijter, Joelle E. T.
    Olsen, Michael H.
    MaassenVanDenBrink, Antoinette
    Terwindt, Gisela M.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [36] Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
    Gantenbein, Andreas R.
    Agosti, Reto
    Gobbi, Claudio
    Flugel, Dominique
    Schankin, Christoph J.
    Viceic, Dragana
    Zecca, Chiara
    Pohl, Heiko
    CEPHALALGIA, 2021, 41 (11-12) : 1181 - 1186
  • [37] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Charleston, Larry
    Talon, Brian
    Sullivan, Christine
    Anderson, Carlton
    Kymes, Steven
    Regnier, Stephane A. A.
    Soni-Brahmbhatt, Seema
    Nahas, Stephanie J. J.
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
  • [38] Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine
    Ceccardi, Giulia
    di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Di Pasquale, Michele
    Bolchini, Marco
    Padovani, Alessandro
    Rao, Renata
    TOXINS, 2023, 15 (12)
  • [39] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Larry Charleston
    Brian Talon
    Christine Sullivan
    Carlton Anderson
    Steven Kymes
    Stephane A. Regnier
    Seema Soni-Brahmbhatt
    Stephanie J. Nahas
    The Journal of Headache and Pain, 24
  • [40] An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine
    Romozzi, Marina
    Lokhandwala, Ammar
    Vollono, Catello
    Vigani, Giulia
    Burgalassi, Andrea
    Garcia-Azorin, David
    Calabresi, Paolo
    Chiarugi, Alberto
    Geppetti, Pierangelo
    Iannone, Luigi Francesco
    CEPHALALGIA, 2024, 44 (12)
12345